Tacrolimus and nonsteroidal anti-inflammatory drugs:: An association to be avoided

被引:15
作者
Soubhia, RMC
Mendes, GEF
Mendonça, FZ
Baptista, MAS
Cipullo, JP
Burdmann, EA
机构
[1] Sao Jose do Rio Preto Med Sch, Div Nephrol, Sao Paulo, Brazil
[2] Sao Jose do Rio Preto Med Sch, Div Internal Med, Sao Paulo, Brazil
关键词
acute nephrotoxicity; acute renal failure; nonsteroidal anti-inflammatory drugs; tacrolimus; diclofenac; rofecoxib; COX-1; COX-2; selective cyclooxygenase inhibitors;
D O I
10.1159/000086569
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Tacrolimus (FK) and nonsteroidal anti-inflammatory drugs (NSAIDs) can cause acute nephrotoxicity. The expanding use of tacrolimus and the intense consumption of NSAIDS increase the chances of their simultaneous use. Methods: Rats receiving a nonselective COX inhibitor (diclofenac, D) and FK or a selective COX-2 inhibitor (rofecoxib, RO) and FK were treated with FK (2 mg/kg/day), D (10 mg/kg/day), RO (3 mg/kg/day), FK+D, FK+RO and vehicle for 7 days on low-salt diet. Results: Both associations significantly impaired glomerular filtration rate (GFR; 0.63 +/- 0.06 ml/min/100 g in FK+D, 0.83 +/- 0.06 ml/min/100 g in FK+RO) which did not occur with single drug therapy (0.98 +/- 0.03 ml/min/100 g in D, 1.06 +/- 0.04 ml/min/100 g in RO, 0.99 +/- 0.05 ml/min/ 100 g in FK) or vehicle (1.10 +/- 0.05 ml/min/100 g). GFR decrease was significantly higher with FK+D. GFR impairment occurred without RBF or RVR major changes. Mild tubular vacuolization and dilatation and acute degenerative changes were observed in tubular cells. FK+D animals showed a marked weight loss, not observed in the other groups. FK+NSAIDs association decreased FK blood levels (1.73 +/- 0.3 ng/ml in FK+D, 1.8 +/- 0.3 ng/ml in FK+RO, 3.2 +/- 0.4 ng/ml in FK, p < 0.05). Conclusions: The association of FK and nonselective or COX-2 selective NSAIDs in salt-depleted animals caused a significant GFR impairment and decreased FK blood levels. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:327 / 334
页数:8
相关论文
共 38 条
  • [11] Identification of drugs inhibiting the in vitro metabolism of tacrolimus by human liver microsomes
    Christians, U
    Schmidt, G
    Bader, A
    Lampen, A
    Schottmann, R
    Linck, A
    Sewing, KF
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 41 (03) : 187 - 190
  • [12] Pharmacology of immunosuppressive medications used in renal diseases and transplantation
    deMattos, AM
    Olyaei, AJ
    Bennett, WM
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (05) : 631 - 667
  • [13] DERAY G, 1987, CLIN NEPHROL, V27, P213
  • [14] Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors
    Gambaro, G
    Perazella, MA
    [J]. JOURNAL OF INTERNAL MEDICINE, 2003, 253 (06) : 643 - 652
  • [15] FK-506 - EFFECTS ON GLOMERULAR HEMODYNAMICS AND ON MESANGIAL CELLS IN CULTURE
    HADAD, SJ
    SOUZA, ERM
    FERREIRA, AT
    OSHIRO, MEM
    BOIM, MA
    RAZVICKAS, CV
    MOURA, LAR
    SCHOR, N
    [J]. KIDNEY INTERNATIONAL, 1995, 48 (01) : 56 - 64
  • [16] Harris RC, 2000, J AM SOC NEPHROL, V11, P2387, DOI 10.1681/ASN.V11122387
  • [17] UROLINK: a model for working together in a changing world
    Harrison, NW
    [J]. BJU INTERNATIONAL, 2002, 89 : 1 - 5
  • [18] The cyclooxygenase-2 inhibitors: Safety and effectiveness
    Kaplan-Machlis, B
    Klostermeyer, BS
    [J]. ANNALS OF PHARMACOTHERAPY, 1999, 33 (09) : 979 - 988
  • [19] Interspecies differences in renal localization of cyclooxygenase isoforms: Implications in nonsteroidal antiinflammatory drug-related nephrotoxicity
    Khan, KNM
    Venturini, CM
    Bunch, RT
    Brassard, JA
    Koki, AT
    Morris, DL
    Trump, BF
    Maziasz, TJ
    Alden, CL
    [J]. TOXICOLOGIC PATHOLOGY, 1998, 26 (05) : 612 - 620
  • [20] Kondo H, 2004, J RHEUMATOL, V31, P243